Delivery Order SPE2DB24D1205-SPE2DB25FCQTK

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCQTK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The award, valued at $1,726.75, is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract has an ultimate completion date of October 15, 2024 and was awarded on October 11, 2024 as a Firm Fixed Price Delivery Order. The contract is not associated with any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, to supply a wide range of critical pharmaceutical and medical products to support the healthcare needs of the military, veterans, and other federal beneficiaries.

Generated 1/10/25, 9:14 AM